> top > docs > PubMed:32023685 > spans > 432-646 > annotations

PubMed:32023685 / 432-646 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PAS-Enju

Id Subject Object Predicate Lexical cue
EnjuParser_T69 0-9 JJ denotes Antiviral
EnjuParser_T70 10-15 NNS denotes drugs
EnjuParser_T71 16-24 RB denotes commonly
EnjuParser_T72 25-29 VBN denotes used
EnjuParser_T73 30-32 IN denotes in
EnjuParser_T74 33-41 JJ denotes clinical
EnjuParser_T75 42-50 NN denotes practice
EnjuParser_T76 50-51 -COMMA- denotes ,
EnjuParser_T77 52-61 VBG denotes including
EnjuParser_T78 62-75 NN denotes neuraminidase
EnjuParser_T79 76-86 NNS denotes inhibitors
EnjuParser_T80 87-88 -LRB- denotes (
EnjuParser_T81 88-99 NN denotes oseltamivir
EnjuParser_T82 99-100 -COMMA- denotes ,
EnjuParser_T83 101-110 NN denotes paramivir
EnjuParser_T84 110-111 -COMMA- denotes ,
EnjuParser_T85 112-121 NN denotes zanamivir
EnjuParser_T86 121-122 -COMMA- denotes ,
EnjuParser_T87 123-127 FW denotes etc.
EnjuParser_T88 127-128 -RRB- denotes )
EnjuParser_T89 128-129 -COMMA- denotes ,
EnjuParser_T90 130-141 NN denotes ganciclovir
EnjuParser_T91 141-142 -COMMA- denotes ,
EnjuParser_T92 143-152 NN denotes acyclovir
EnjuParser_T93 153-156 CC denotes and
EnjuParser_T94 157-166 NN denotes ribavirin
EnjuParser_T95 166-167 -COMMA- denotes ,
EnjuParser_T96 168-171 VBP denotes are
EnjuParser_T97 172-179 JJ denotes invalid
EnjuParser_T98 180-183 IN denotes for
EnjuParser_T99 184-193 NN denotes 2019-nCoV
EnjuParser_T100 194-197 CC denotes and
EnjuParser_T101 198-201 RB denotes not
EnjuParser_T102 202-213 VBN denotes recommended
EnjuParser_R69 EnjuParser_T70 EnjuParser_T69 arg1Of drugs,Antiviral
EnjuParser_R70 EnjuParser_T72 EnjuParser_T71 arg1Of used,commonly
EnjuParser_R71 EnjuParser_T70 EnjuParser_T72 arg2Of drugs,used
EnjuParser_R72 EnjuParser_T72 EnjuParser_T73 arg1Of used,in
EnjuParser_R73 EnjuParser_T75 EnjuParser_T73 arg2Of practice,in
EnjuParser_R74 EnjuParser_T75 EnjuParser_T74 arg1Of practice,clinical
EnjuParser_R75 EnjuParser_T70 EnjuParser_T76 arg1Of drugs,","
EnjuParser_R76 EnjuParser_T70 EnjuParser_T77 arg1Of drugs,including
EnjuParser_R77 EnjuParser_T89 EnjuParser_T77 arg2Of ",",including
EnjuParser_R78 EnjuParser_T79 EnjuParser_T78 arg1Of inhibitors,neuraminidase
EnjuParser_R79 EnjuParser_T79 EnjuParser_T80 arg1Of inhibitors,(
EnjuParser_R80 EnjuParser_T81 EnjuParser_T80 arg2Of oseltamivir,(
EnjuParser_R81 EnjuParser_T88 EnjuParser_T80 arg3Of ),(
EnjuParser_R82 EnjuParser_T81 EnjuParser_T82 arg1Of oseltamivir,","
EnjuParser_R83 EnjuParser_T83 EnjuParser_T82 arg2Of paramivir,","
EnjuParser_R84 EnjuParser_T81 EnjuParser_T84 arg1Of oseltamivir,","
EnjuParser_R85 EnjuParser_T85 EnjuParser_T84 arg2Of zanamivir,","
EnjuParser_R86 EnjuParser_T81 EnjuParser_T86 arg1Of oseltamivir,","
EnjuParser_R87 EnjuParser_T81 EnjuParser_T87 arg1Of oseltamivir,etc.
EnjuParser_R88 EnjuParser_T79 EnjuParser_T89 arg1Of inhibitors,","
EnjuParser_R89 EnjuParser_T90 EnjuParser_T89 arg2Of ganciclovir,","
EnjuParser_R90 EnjuParser_T70 EnjuParser_T91 arg1Of drugs,","
EnjuParser_R91 EnjuParser_T93 EnjuParser_T91 arg2Of and,","
EnjuParser_R92 EnjuParser_T92 EnjuParser_T93 arg1Of acyclovir,and
EnjuParser_R93 EnjuParser_T94 EnjuParser_T93 arg2Of ribavirin,and
EnjuParser_R94 EnjuParser_T96 EnjuParser_T95 arg1Of are,","
EnjuParser_R95 EnjuParser_T91 EnjuParser_T96 arg1Of ",",are
EnjuParser_R96 EnjuParser_T97 EnjuParser_T96 arg2Of invalid,are
EnjuParser_R97 EnjuParser_T91 EnjuParser_T97 arg1Of ",",invalid
EnjuParser_R98 EnjuParser_T97 EnjuParser_T98 arg1Of invalid,for
EnjuParser_R99 EnjuParser_T99 EnjuParser_T98 arg2Of 2019-nCoV,for
EnjuParser_R100 EnjuParser_T99 EnjuParser_T100 arg1Of 2019-nCoV,and
EnjuParser_R101 EnjuParser_T102 EnjuParser_T101 arg1Of recommended,not
EnjuParser_R102 EnjuParser_T99 EnjuParser_T102 arg2Of 2019-nCoV,recommended

LitCovid-ArguminSci

Id Subject Object Predicate Lexical cue
T4 0-127 DRI_Background denotes Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.
T5 127-214 DRI_Background denotes ), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.

LitCovid-OGER

Id Subject Object Predicate Lexical cue
T1 0-15 CHEBI:36044 denotes Antiviral drugs
T2 76-86 CHEBI:35222 denotes inhibitors
T3 88-99 CHEBI:7798 denotes oseltamivir
T4 112-121 CHEBI:50663 denotes zanamivir
T5 130-141 CHEBI:465284 denotes ganciclovir
T6 143-152 CHEBI:2453 denotes acyclovir
T7 157-166 CHEBI:63580 denotes ribavirin
T1 168-171 SO:0001853 denotes are

LitCovid-PubTatorCentral

Id Subject Object Predicate Lexical cue
T6 88-99 Chemical:MESH:D053139 denotes oseltamivir
T7 101-110 Chemical: denotes paramivir
T8 112-121 Chemical:MESH:D053243 denotes zanamivir
T9 130-141 Chemical:MESH:D015774 denotes ganciclovir
T10 143-152 Chemical:MESH:D000212 denotes acyclovir
T11 157-166 Chemical:MESH:D012254 denotes ribavirin

LitCovid-sentences-v1

Id Subject Object Predicate Lexical cue
TextSentencer_T4 0-214 Sentence denotes Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.

LitCovid-TimeML

Id Subject Object Predicate Lexical cue
tok77 0-9 NNP denotes Antiviral
tok78 10-15 NNS denotes drugs
tok79 16-24 RB denotes commonly
tok80 25-29 VBN denotes used
tok81 30-32 IN denotes in
tok82 33-41 JJ denotes clinical
tok83 42-50 NN denotes practice
tok84 50-51 , denotes ,
tok85 52-61 VBG denotes including
tok86 62-75 NN denotes neuraminidase
tok87 76-86 NNS denotes inhibitors
tok88 87-88 ( denotes (
tok89 88-99 NN denotes oseltamivir
tok90 99-100 , denotes ,
tok91 101-110 NN denotes paramivir
tok92 110-111 , denotes ,
tok93 112-121 NN denotes zanamivir
tok94 121-122 , denotes ,
tok95 123-126 FW denotes etc
tok96 126-127 . denotes .
tok97 127-128 ) denotes )
tok98 128-129 , denotes ,
tok99 130-141 NN denotes ganciclovir
tok100 141-142 , denotes ,
tok101 143-152 NN denotes acyclovir
tok102 153-156 CC denotes and
tok103 157-166 NN denotes ribavirin
tok104 166-167 , denotes ,
tok105 168-171 VBP denotes are
tok106 172-179 JJ denotes invalid
tok107 180-183 IN denotes for
tok108 184-188 CD denotes 2019
tok109 188-189 : denotes -
tok110 189-193 NN denotes nCoV
tok111 194-197 CC denotes and
tok112 198-201 RB denotes not
tok113 202-213 VBD denotes recommended
tok114 213-214 . denotes .
lookup19 30-32 country_code denotes in
lookup20 184-188 year denotes 2019
event6 25-29 OCCURRENCE denotes used
event8 202-213 OCCURRENCE denotes recommended

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T3 10-15 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T4 62-86 Chemical denotes neuraminidase inhibitors http://purl.obolibrary.org/obo/CHEBI_52425
T5 76-86 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T6 88-99 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T7 112-121 Chemical denotes zanamivir http://purl.obolibrary.org/obo/CHEBI_50663
T8 130-141 Chemical denotes ganciclovir http://purl.obolibrary.org/obo/CHEBI_465284
T9 143-152 Chemical denotes acyclovir http://purl.obolibrary.org/obo/CHEBI_2453
T10 157-166 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
33 62-75 Gene denotes neuraminidase Gene:4758
34 88-99 Chemical denotes oseltamivir MESH:D053139
35 101-110 Chemical denotes paramivir
36 112-121 Chemical denotes zanamivir MESH:D053243
37 130-141 Chemical denotes ganciclovir MESH:D015774
38 143-152 Chemical denotes acyclovir MESH:D000212
39 157-166 Chemical denotes ribavirin MESH:D012254
40 184-193 Species denotes 2019-nCoV Tax:2697049

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 0-214 Sentence denotes Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended.